{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PC3", "Tricin", "docetaxel", "miR-21", "proliferation"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29447469", "DateCompleted": {"Year": "2019", "Month": "09", "Day": "03"}, "DateRevised": {"Year": "2019", "Month": "09", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "02", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.1080/14786419.2018.1437439"], "Journal": {"ISSN": "1478-6427", "JournalIssue": {"Volume": "33", "Issue": "12", "PubDate": {"Year": "2019", "Month": "Jun"}}, "Title": "Natural product research", "ISOAbbreviation": "Nat Prod Res"}, "ArticleTitle": "Tricin isolated from <i>Allium atroviolaceum</i> potentiated the effect of docetaxel on PC3 cell proliferation: role of miR-21.", "Pagination": {"StartPage": "1828", "EndPage": "1831", "MedlinePgn": "1828-1831"}, "Abstract": {"AbstractText": ["For more effectiveness and overcoming the drug resistance Chemotherapy agents, the combination treatment is raised. Flavonoids with different anti-cancer effects are an appropriate choice as lead compounds. Over expressed MiR-21 in prostate cancer is associated with metastasis and drug resistance to chemotherapy with Docetaxel. In this study, the anticancer effect of 4', 5, 7-Trihydroxy-3', 5'-dimethoxyflavone (Tricin) was investigated with Docetaxel on PC3 cell line. Tricin was initially isolated from the <i>Allium atroviolaceum</i> by column chromatography and recrystallization method. The chemical structure of isolate was elucidated by spectroscopic techniques. IC<sub>50</sub> of Tricin and Docetaxel were assessed 117.5\u00a0\u00b1\u00a04.4\u00a0\u03bcM and 0.1\u00a0\u00b1\u00a00.02 nM by MTT assay, respectively. Analysis of results indicates the synergistic effect of combination therapy on decreased proliferation. MiR-21 in treated cells with Tricin significantly decreased compared to control cells. So, Tricin can be effective in the reduction of metastasis and drug resistance of Docetaxel."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences , Shahrekord , Iran."}], "LastName": "Ghasemi", "ForeName": "Sorayya", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Medicinal Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences , Shahrekord , Iran."}], "LastName": "Lorigooini", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": ["0000-0003-4080-3724"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "c Chemical and Pharmaceutical Biology Department , Groningen Research Institute of Pharmacy, University of Groningen , Groningen , The Netherlands."}, {"Identifier": [], "Affiliation": "d Faculty of Pharmacy , University of Muhammadiyah Banjarmasin , Banjarmasin , Indonesia."}], "LastName": "Wibowo", "ForeName": "JokoPriyanto", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Medicinal Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences , Shahrekord , Iran."}], "LastName": "Amini-Khoei", "ForeName": "Hossein", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Video-Audio Media"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Nat Prod Res", "NlmUniqueID": "101167924", "ISSNLinking": "1478-6419"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "MIRN21 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "15H5577CQD", "NameOfSubstance": "Docetaxel"}, {"RegistryNumber": "D51JZL38TQ", "NameOfSubstance": "tricin"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Allium"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Docetaxel"}, {"QualifierName": ["genetics"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["administration & dosage", "isolation & purification"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["genetics"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["drug therapy", "genetics", "pathology"], "DescriptorName": "Prostatic Neoplasms"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "16", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29447469", "10.1080/14786419.2018.1437439"]}}]}